Breast cancer is the most common cancer in women globally. Survival from this complex disease is limited by challenges that include the development of drug resistance. These challenges necessitate the discovery and development of novel therapeutic targets and the improvement of treatment regimes. In this study, led by Prof. Bay Boon Huat and A/Prof George Yip, the authors investigated the role of C1QBP in breast cancer progression, where C1QBP is a protein which has shown both an association with breast cancer and potential as a cancer therapeutic target in preliminary studies. Findings from this study provide a deeper understanding of the role of C1QBP in breast cancer and potentially lay the foundation for future development of C1QBP-targeted therapy for breast cancer.
Read more: https://www.mdpi.com/1422-0067/24/2/1343
